Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Application of antibacterial peptide in in-vitro inhibition of Escherichia coli

A technology of Escherichia coli and antibacterial peptides, applied in the field of cell biology, can solve the problems of inability to meet in vitro sterilization, general sterilization effect, poor sterilization effect, etc.

Active Publication Date: 2020-09-15
广州颜如玉生物科技有限公司
View PDF6 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the function of the currently known synthetic antimicrobial peptides is mainly to inhibit Gram-negative bacteria and fungi, and their bactericidal effect is not good
[0005] Chinese patent CN1629837C discloses a group of synthetic antimicrobial peptides, which have stronger bactericidal activity than natural antimicrobial peptides, and can be used to prepare drugs for treating diseases caused by Gram-negative bacteria, Gram-positive bacteria and fungal infections ; This antimicrobial peptide is only suitable for in vivo sterilization, and the bactericidal effect is average, and it cannot achieve the purpose of strong sterilization in vitro
[0006] To sum up, the ubiquitous defect in the prior art is that the bactericidal effect is average, and most of them are sterilized in vivo, which cannot meet the needs of in vitro sterilization.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of antibacterial peptide in in-vitro inhibition of Escherichia coli
  • Application of antibacterial peptide in in-vitro inhibition of Escherichia coli
  • Application of antibacterial peptide in in-vitro inhibition of Escherichia coli

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0021] A kind of pharmaceutical composition of embodiment 1

[0022] The pharmaceutical composition comprises 0.15 g of a mixture of antimicrobial peptide Esculentin-1A and citric acid in a mass ratio of 7:2, 600 mL of normal saline, 0.8 mL of lubricant hydrogenated vegetable oil, 1.3 g of cross-linking agent sodium alginate, apple salt 5g, preservative potassium sorbate 1.3g.

[0023] The preparation process of the pharmaceutical composition is as follows: heating the water for injection to 65° C., and then respectively adding a mixture composed of antibacterial peptide Esculentin-1A and citric acid, a lubricant hydrogenated vegetable oil, a cross-linking agent sodium alginate, malate, Preservative potassium sorbate, stirred at 400rpm for 30min, until mixed evenly and completely dissolved, cooled to 25°C to obtain.

Embodiment 2

[0024] A kind of pharmaceutical composition of embodiment 2

[0025] The ingredients and preparation method of the pharmaceutical composition are similar to those in Example 1, the difference from Example 1 is that the mixture in Example 2 is composed of antibacterial peptide Esculentin-1A and citric acid in a mass ratio of 7-10:2-5 proportional composition.

Embodiment 3

[0026] A kind of pharmaceutical composition of embodiment 3

[0027] The ingredients and preparation method of the pharmaceutical composition are similar to those of Example 1, the difference from Example 1 is that the mixture in Example 3 is composed of antibacterial peptide Esculentin-1A and citric acid in a mass ratio of 9:4.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
diameteraaaaaaaaaa
Login to View More

Abstract

The invention belongs to the field of cell biology, and particularly relates to an application of an antibacterial peptide in the in-vitro inhibition of Escherichia coli. The antibacterial peptide selected by the invention is a natural antibacterial peptide Esculentin-1A, and the amino acid sequence information of the antibacterial peptide Esculentin-1A is shown as SEQ ID NO.1. In the research process, it is found that the antibacterial peptide Esculentin-1A and citric acid are mixed according to a mass ratio of (7-10):(2-5), and in-vitro tests prove that the inhibition of the mixture on Escherichia coli reaches 99% or more. The antibacterial peptide and citric acid are mixed for use for the first time, and a new research and development direction is provided for the development of drugs related to the treatment of symptoms such as cholecystitis and ovaritis caused by Escherichia coli infection.

Description

technical field [0001] The invention belongs to the field of cell biology, and in particular relates to the application of an antimicrobial peptide in inhibiting Escherichia coli in vitro. Background technique [0002] Antimicrobial peptide refers to a class of basic polypeptide substances with antibacterial activity induced by insects, with a molecular weight of about 2000-7000 and composed of 20-60 amino acid residues. Most of these active peptides have the characteristics of strong alkalinity, thermal stability and broad-spectrum antibacterial properties. It can be seen from the published literature on antimicrobial peptides that, in addition to the different sources of classification, according to their structure and characteristics, the following three classification methods are common. One is to divide antimicrobial peptides into five categories: cecropins, magainins, defensins, tachyplesins and endogenous cathelicidins. According to the secondary structure and confo...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K38/16A61K31/194A61P31/04A61P1/16A61P1/00A61P29/00
CPCA61K31/194A61K38/16A61P1/00A61P1/16A61P29/00A61P31/04A61K2300/00Y02A50/30
Inventor 王中振谢涛
Owner 广州颜如玉生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products